Publications of Udo Reichl

Küchler, J.; Opitz, P.; Kupke, S. Y.; Genzel, Y.; Benndorf, D.; Reichl, U.: Absolute quantification of influenza A virus proteins during single-round replication in vaccine producer cell lines. 16^th PEACe (Protein Expression in Animal Cells) Conference, Sitges (Spain) (2023)

Lemke, G.; Zuniga-Banuelos, F. J.; Grote, V.; Hoffmann, M.; Rapp, E.; Reichl, U.: N-glycan Sulfation on Human IgA: In-Depth N-glycoproteomic Analyses of Sulfated N-glycan Site-Specificity and Distribution on Human IgA Isotypes. GlycoBioTec 2023, Berlin, Germany (2023)

Pelz, L.; Dogra, T.; Boehme, J.D.; Hein, M. D.; Marichal-Gallardo, P.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivo. Cell Culture Engineering (CCE) XVIII , Cancun (Mexico) (2023)

Pelz, L.; Dogra, T.; Boehme, J.D.; Marichal-Gallardo, P.; Hein, M. D.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: A Scalable High-Yield Process for Production of Influenza A Virus Defective Interfering Particles and In Vivo Studies. Himmelfahrtstagung on Bioprocess Engineering 2023, Weimar (Germany) (2023)

Pelz, L.; Dogra, T.; Boehme, J.D.; Marichal-Gallardo, P.; Hein, M. D.; Genzel, Y.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Influenza A Virus Chimeric OP7 Defective Interfering Particles: Cell Culture-based Production and In Vivo Antiviral Efficacy. 32^nd Annual Meeting of the Society for Virology (GFV), Ulm (Germany) (2023)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviral. 8^th European Congress of Virology, Gdańsk (Poland) (2023)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7. 32^nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)

Piasecka, J.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. 17^th Vaccine Congress, Glasgow (Scotland) (2023)

Rexer, T.; Alcalá Orozco, E. A.; Hoang Son, T.; Kleeberg, S.; Reichl, U.: Platform for the scalable synthesis of human milk oligosaccharides. The Origins and Benefits of Biologically Active Components in Human Milk Conference, Florida, USA (2023)

Sultan Mohideen, M. A. H.; Khesali Aghtaei, H.; Reichl, U.; Benndorf, D.: Development of a packed foam bed bioreactor for biological methanation. 6th International Conference on Monitoring and Control of Anaerobic Digestion Processes, Leipzig, Germany (2023)

Wenzel, L.; Ruhnau, J.; Hoffmann, M.; Rexer, T.; Reichl, U.: Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme Cascade. GlycoBioTec 2023, Berlin, Germany (2023)

Zuniga-Banuelos, F. J.; Hoffmann, M.; Budimir, I.; Reichl, U.; Rapp, E.: New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N-Glycoproteome. GlycoBioTec 2023, Berlin, Germany (2023)

Alcalá Orozco, E. A.; Hoang Son, T.; Rexer, T.; Reichl, U.: In vitro multi-enzyme cascades for the synthesis of nucleotide sugars. INTERfaces Conference on ‘Intensifying Biocatalytic Processes – From Enzyme and Material Design to Industrial Applications’ (IBPRO2022), Bielefeld, Germany (2022)

Dogra, T.; Pelz, L.; Marc, H.; Rüdiger, D.; Boehme, J.; Bruder, D.; Kupke, S. Y.; Reichl, U.: Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Göbel, S.; Dorn, M.; Jaén Chavez, K.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processes. Vaccine Technology VIII, Sitges (Spain) (2022)

Göbel, S.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Towards the production of a fusogenic oncolytic rVSV-NDV virus in perfusion mode. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Göbel, S.; Kortum, F.; Jaén Chavez, K.; Jordan, I.; Sandig, V.; Altomonte, J.; Genzel, Y.; Reichl, U.: Production of a fusogenic oncolytic VSV-NDV virus: cell-line screening and process development in small-scale suspension cultures. Advancing Manufacture of Cell and Gene Therapies VII, Coronado, CA (USA) (2022)

Hein, M.; Chawla, A.; Arora , P.; Cattaneo, M.; Winkler, M.; Pöhlmann, S.; Genzel, Y.; Kupke, S. Y.; Reichl, U.: Production of influenza A virus-derived defective interfering particles for antiviral therapy in a high cell density perfusion cultivation. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Hellwig, P.; Dittrich, A.; Benndorf, D.; Reichl, U.: Establishment of a click chemistry-based method for detection and characterizationof phage-host systems in anaerobic digestion. 2nd German Phage Symposium, Stuttgart, Germany (2022)

Hellwig, P.; Heyer, R.; Maus, I.; Meinusch, N.; Walke, D.; Schlüter, A.; Hassa, J.; Sczyrba, A.; Klocke, M.; Mächtig, T. et al.; Schallert, K.; Seick, I.; Saake, G.; Reichl, U.; Benndorf, D.: Combined metagenomics and metaproteomics for analysis of the microbial community in a two-stage biogas plant. XIV Annual Congress of the European Proteomic Association, Leipzig, Germany (2022)